The Emerging Oncogenic Role of RARγ: From Stem Cell Regulation to a Potential Cancer Therapy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094357 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Geoffrey Brown. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Edgba…. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation (UKRI).
Abstract (Originalsprache)
Retinoic acid receptor (RAR) γ expression is restricted during adult haematopoiesis to haematopoietic stem cells and their immediate offspring and is required for their maintenance. From zebrafish studies, RARγ is selectively expressed by stem cells and agonism in the absence of exogenous all-trans retinoic acid blocked stem cell development. Recent findings for the expression of RARγ have revealed an oncogenic role in acute myeloid leukaemia and cholangiocarcinoma and colorectal, head and neck, hepatocellular, ovarian, pancreatic, prostate, and renal cancer. Overexpression and agonism of RARγ enhanced cell proliferation for head and neck, hepatocellular, and prostate cancer. RARγ antagonism, pan-RAR antagonism, and RARγ downregulation led to cell growth which was often followed by cell death for acute myeloid leukaemia, astrocytoma, and cholangiocarcinoma as well as hepatocellular, primitive, neuroectodermal ovarian, and prostate cancer. Histological studies have associated high level RARγ expression with high-grade disease, metastasis, and a poor prognosis for cholangiocarcinoma and ovarian, pancreatic, and prostate cancer. RARγ is expressed by cancer stem cells and is a targetable drive of cancer cell growth and survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
ORCID-Profile: Geoffrey Brown
Förderung
- UK Research and Innovation (UKRI)
Zitieren
APA
Brown, G. (2025). The Emerging Oncogenic Role of RARγ: From Stem Cell Regulation to a Potential Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094357
Vancouver
Brown G. The Emerging Oncogenic Role of RARγ: From Stem Cell Regulation to a Potential Cancer Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094357
BibTeX
@article{Brown2025,
author = {Brown, Geoffrey},
title = {The Emerging Oncogenic Role of RARγ: From Stem Cell Regulation to a Potential Cancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094357}
}
EUVIMED